Advertisement
Advertisement

GRFS

GRFS logo

Grifois, S.A.

7.94
USD
Sponsored
+0.11
+1.40%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

7.95

+0.01
+0.13%

Grifois, S.A. Profile

About

Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.

Info & Links

CEO

Jos� Ignacio

Headquarters

152-158 PARC DE NEGOCIS CAN SANT JOAN , SANT CUGAT DEL VALL�S
BARCELONA, U3 08174, SPAIN

Industry

Medical Drugs

Sector

Medical

Website

https://www.grifols.com

Auditor

KPMG Auditores, S.L.

Share holders

--

Employees

25,247

Grifois, S.A. Statistics

Valuation Measures

Market Capitalization2

5.41B

Enterprise Value

15.91B

Enterprise Value/EBITDA(ttm)

8.24

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.63

Price to Book(mrq)

0.58

Price to Cash(ytd)

5.60

Profitability

Gross Margin(ttm)

27.64%

Operating Margin(ttm)

6.35%

Profit Margin(ttm)

3.98%

Return on Equity(ttm)

6.21%

Return on Invested Capital(ttm)

2.14%

Return on Assets(ttm)

2.39%

Income Statement

Revenue(ttm)

8.62B

Revenue Per Share(ttm)

--

Gross Profit(ttm)

3.23B

EBITDA(ttm)3

1.93B

Net Income Available to Common(ttm)

477.34M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.67

52-Week Change

-24.24%

S&P 500 52-Week Change

21.41%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

2.88%

Float4

679.28M

% Held by Insiders

0.19%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

887.16M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

11.32B

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

0.81%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement